Therapeutic vaccination with epidermal growth factor (EGF) in advanced lung cancer: analysis of pooled data from three clinical trials.
about
Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patientsNovel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialLung cancer: a classic example of tumor escape and progression while providing opportunities for immunological interventionTherapeutic vaccines in non-small cell lung cancerLung cancer vaccinesRacotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical dataRacotumomab-alum vaccine for the treatment of non-small-cell lung cancer.Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-β1Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer VaccinesActive immunization with human interleukin-15 induces neutralizing antibodies in non-human primates.Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic realityAntitumor activity of pluripotent cell-engineered vaccines and their potential to treat lung cancer in relation to different levels of irradiationCIMAvax EGF vaccine for stage IIIb/IV non-small cell lung carcinoma.Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it's potential therapeutic implications.Effect of blockade of the EGF system on wound healing in patients vaccinated with CIMAvax® EGF.Non-small-cell lung carcinoma vaccines in clinical trials.Therapeutic vaccination with an EGF-based vaccine in lung cancer: a step in the transition to a chronic disease.Active immunotherapy for non-small-cell lung cancer: moving toward a reality.Epidermal growth factor vaccine in non-small-cell lung cancer.Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer.Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines.Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants.Active-specific immunotherapy for non-small cell lung cancer.Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants.Immunotherapy as a strategy for the treatment of non-small-cell lung cancer.An enzyme immunoassay for determining epidermal growth factor (EGF) in human serum samples using an ultramicroanalytical system.New Approaches in Immunotherapy for the Treatment of Lung Cancer.Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancer.
P2860
Q21245661-CEDFD6D6-4EDD-499C-B10A-3AF69BDDA3D0Q26769884-2AF23E3A-25DE-4917-9CC5-729DF18EA4E9Q26850218-51351A15-01EE-41FC-8143-D1295F0382A1Q26864896-3D1E5949-E7DE-4B87-9626-FDDA728BEA10Q27014375-00DFB168-D073-4FB2-85AE-075C860A7DEEQ30575331-5D0347B6-6CA7-4FDF-8529-7F9BE50F9B9CQ34449304-6C26EB49-BA65-464D-B95B-32C4787D2800Q35070050-11D9203F-EB2C-4D94-A7A5-3CCE94E7C178Q35774908-BF48B07D-C432-4940-9817-1CA0B5FC8C19Q36145575-BBB7DAE7-654B-4953-BD02-ABC8CFDD4A84Q36326572-94015AAF-AEBA-49F5-A511-27C08B080AD3Q36697093-E2684CD8-A554-42E8-9DAE-3CD1300C5B94Q36849784-49260CE6-A57F-4CE6-B5CC-577FDCFCFCBCQ37280403-862F62C7-CD55-41CA-B9DD-E528827802BBQ37369449-DC2A0F8E-2CF1-4D5B-B96D-13DF10612C25Q37892598-B22174B2-0836-4DEE-9D07-DE74334AFA5BQ37894088-A4428C33-3CAE-4057-9B83-DFC52C220515Q37945644-5E0FE49D-94BE-4413-B889-7A0A8CE95BB6Q38002466-EE79F883-1DFD-4C7E-9ECF-C9166F8B02A9Q38002896-C6150EDF-3F85-4271-838C-4BB86E0C743CQ38230278-AAF75DA0-B003-49D2-8CD3-EA86F8355FCAQ39912219-8737EA3C-BD7C-4448-9E74-74B872C442A4Q40342047-1578C3E4-07BD-4AA6-B0CE-7F0BC9E6C3B2Q41147045-9BF313D9-93AD-4D2B-B3DA-973CDB49F1F9Q41878129-70264BBF-6F0D-4738-8782-158E1F1BDA48Q51498835-6DDDB7D0-3079-4483-B3D7-592F469B4D45Q52871134-98521AD5-1E55-495A-B13A-4A6919C57208Q55045138-63A41EE1-2234-4EC7-80EA-1D66C156C342
P2860
Therapeutic vaccination with epidermal growth factor (EGF) in advanced lung cancer: analysis of pooled data from three clinical trials.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Therapeutic vaccination with e ...... ta from three clinical trials.
@ast
Therapeutic vaccination with e ...... ta from three clinical trials.
@en
type
label
Therapeutic vaccination with e ...... ta from three clinical trials.
@ast
Therapeutic vaccination with e ...... ta from three clinical trials.
@en
prefLabel
Therapeutic vaccination with e ...... ta from three clinical trials.
@ast
Therapeutic vaccination with e ...... ta from three clinical trials.
@en
P2093
P356
P1433
P1476
Therapeutic vaccination with e ...... ta from three clinical trials.
@en
P2093
Agustín Lage
Carmen Viada
Elia Neninger
Gisela González
Tania Crombet
P356
10.4161/HV.3.1.3537
P577
2007-01-22T00:00:00Z